Zenrelia is now in roughly 18,000 US clinics, driving a 26% EPS beat that lifted full-year adjusted EPS guidance to $1.10 to $1.16. Credelio Quattro already covers more than half the US clinic base, so the innovation ramp has room to run into Q3.
Elanco Animal Health :
ELAN
ELAN
Stock Data
$22.12
$2.08 (8.60%)
Asset Type
Common Stock
Exchange
NYSE
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Elanco Animal Health Inc is a leading innovator in the animal health sector, focusing on products for both pets and farm animals. With a rich history since 1954, Elanco provides a wide range of health solutions, including disease prevention and treatment options. Their portfolio features well-known brands like Seresto, Advantage, and Galliprant, catering to issues from parasites in pets to nutritional health in farm animals. Headquartered in Greenfield, Indiana, Elanco serves a global market, distributing its products through veterinarians and various animal producers.
Latest Activity
All Elanco Animal Health Articles
11 Articles